Completed PHASE2 INTERVENTIONAL 1-arm NCT01147159

Biological Standardization of Allergen Extracts of Pollens of Betula Pendula, Phleum Pratense and Mite Extract of Dermatophagoides Pteronyssinus

Biological Standardization of Allergen Extracts of Pollens of Betula Pendula, Phleum Pratense and Mite Extract of Dermatophagoides Pteronyssinus in Patients With Rhinoconjunctivitis With/ Without Asthma Sensitized to Betula Pendula, Dermatophagoides Pteronyssinus and Phleum Pratense An Open-label, Single-center Study

Sponsor: Roxall Medicina España S.A

Conditions Allergy

Interventions Extracts of allergens

Updated 6 times since 2017 Last updated: Apr 28, 2017 Started: Dec 31, 2010 Primary completion: Apr 30, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Allergy, this trial is completed. The trial is conducted by Roxall Medicina España S.A and has accumulated 6 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jun 2017 — Jun 2018 [monthly]

Completed PHASE2

Phase: PHASE1_PHASE2 → PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2017 [monthly]

Completed PHASE1_PHASE2

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Roxall Medicina España S.A
University Hospital, Zürich

Data source: Roxall Medicina España S.A

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland